Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014498 |
---|---|
Receipt number | R000016075 |
Scientific Title | Phase I/II study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemoradiationtherapy for borderline resectable pancreatic cancer (Prep-03/NS014-1) |
Date of disclosure of the study information | 2014/07/07 |
Last modified on | 2017/07/10 15:45:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/07/07 19:43:32 | ||
2 | Update | 2014/07/14 15:30:23 | Acronym |
|
3 | Update | 2014/10/17 09:38:26 | Recruitment status Anticipated trial start date |
|
4 | Update | 2017/07/10 15:45:24 | Name of primary person or sponsor Organization |